NCT07067788View on ClinicalTrials.gov

B.Brilliant Revelation Comparision Study

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

July 30, 2026

Study Completion Date

January 30, 2027

Conditions
Breast Cancer Screening
Interventions
DIAGNOSTIC_TEST

Breast Imaging

Intervention using an FDA-approved mammogram machine.

Trial Locations (1)

19107

Pennsylvania Hospital, Center for Breast Imaging, Philadelphia

All Listed Sponsors
collaborator

Siemens Corporation, Corporate Technology

INDUSTRY

lead

University of Pennsylvania

OTHER